Skip to main content

Global Women’s Health Diagnostics Market to See 7% CAGR Backed by Rising Diagnostic Innovation 2030

 


The global women’s health diagnostics market is set to witness a growth rate of ~7% in the next 5 years. Increasing prevalence of women’s health disorders, growing awareness and government initiatives, advancements in diagnostic technologies, rising demand for point-of-care and at-home testing, and expanding female geriatric population are some of the key factors driving the women’s health diagnostics market. 

Women’s health diagnostics refers to medical tests and screening procedures designed to detect, monitor, and manage health conditions specific to women. These diagnostics cover a broad range of diseases, including breast and cervical cancer, osteoporosis, reproductive and fertility issues, and sexually transmitted infections among others. They utilize advanced technologies such as molecular diagnostics, imaging, next-generation sequencing, and point-of-care testing to enable early detection and personalized treatment and others. With increasing awareness, government initiatives, and technological advancements, women’s health diagnostics play a crucial role in preventive healthcare, improving outcomes, and reducing disease burden through timely and accurate medical intervention.

đź”— Want deeper insights? Download the sample report:
https://meditechinsights.com/womens-health-diagnostics-market/request-sample/

Increasing prevalence of women’s health disorders to propel market demand

The increasing prevalence of women’s health disorders, such as breast cancer, cervical cancer, osteoporosis, and polycystic ovary syndrome, is a major driver of the women’s health diagnostics market. Rising disease prevalence necessitates early detection and continuous monitoring, fueling demand for advanced diagnostic solutions. According to WHO, in 2022, there were 2.3 million women diagnosed with breast cancer and 670,000 deaths globally, highlighting the need for improved screening technologies. Additionally, growing awareness and government initiatives promoting routine screenings are encouraging higher adoption of diagnostic tests. This trend is driving innovation in molecular diagnostics, imaging, and point-of-care testing, enhancing early disease detection and treatment outcomes.

Advancements in diagnostic technologies are driving the market growth

Advancements in diagnostic technologies are driving the women’s health diagnostics market by improving accuracy, efficiency, and accessibility of disease detection. Innovations such as next-generation sequencing, liquid biopsy, AI-powered imaging, and molecular diagnostics enable early and precise identification of conditions like breast and cervical cancer, osteoporosis, and fertility disorders. Additionally, point-of-care and at-home diagnostic solutions provide faster, more convenient testing. These advancements reduce diagnostic errors, enable personalized treatment, and support preventive healthcare, increasing the adoption of cutting-edge diagnostic tools in women’s health.

Competitive Landscape Analysis

The global women’s health diagnostics market is marked by the presence of established and emerging market players such as F. Hoffmann-La Roche Ltd, Hologic, Inc., Quest Diagnostics Incorporated, Abbott, BD, GE Healthcare, Koninklijke Philips N.V., PerkinElmer, Thermo Fisher Scientific Inc., and BIOMÉRIEUX; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.

 Gain a competitive edge-request a sample report now! 
https://meditechinsights.com/womens-health-diagnostics-market/request-sample/

Global Women’s Health Diagnostics Market Segmentation

This report by Medi-Tech Insights provides the size of the global women’s health diagnostics market at the regional- and country-level from 2023 to 2030. The report further segments the market based on, application, end user.

Market Size & Forecast (2023-2030), By Application, USD Million

  • Osteoporosis Testing
  • OVC Testing
  • Cervical Cancer Testing
  • Breast Cancer Testing
  • Pregnancy & Fertility Testing
  • Infectious Disease Testing
  • STD Testing
  • Others

Market Size & Forecast (2023-2030), By End User, USD Million

  • Hospitals & Clinics
  • Diagnostic and Imaging Centers
  • Home Care Settings
  • Others

Market Size & Forecast (2023-2030), By Region, USD Million

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia Pacific
  • Latin America
  • Middle East & Africa

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
Associate, Medi-Tech Insights
 +32 498 86 80 79
 info@meditechinsights.com 

Comments

Post a Comment

Popular posts from this blog

Global Biotechnology Market to grow at 13–15% CAGR as CRISPR use expands globally by 2029

  The global biotechnology market is set to witness a growth rate of 13-15% in the next 5 years.  Advancements in genetic engineering and genomics; growing demand for biopharmaceuticals; rising incidence of chronic diseases; growth in environmental and agricultural biotechnology; increased investment in R&D; growing demand for synthetic biology; and presence of favorable government initiatives are some of the key factors driving the biotechnology market. Biotechnology is the scientific field that uses biological organisms, systems, or processes to develop products and technologies aimed at improving health, agriculture, environmental sustainability, and industrial efficiency. By applying principles of genetics, molecular biology, and biochemistry, biotechnology enables advancements like genetic engineering, biopharmaceutical development, biofuels, and genetically modified organisms (GMOs). This field is instrumental in producing therapies for diseases, increasing crop r...
Post a Comment
Read more

Global Multi Cancer Early Detection Market expanding 15–20% CAGR through personalized care 2030

  The multi cancer early detection market is expected to grow at a CAGR of around 15-20% during the forecast period.  This growth is primarily due to the rising awareness and increasing demand for early-stage screening tools, especially as cancer rates continue to rise globally, and technological advancements in screening methods. However, high costs and strict regulations can still hinder the market growth.  Multi Cancer Early Detection (MCED) refers to tests designed to detect multiple cancers, often from a single blood sample, unlike traditional methods, which can include multiple diagnostic tests or biopsies. These tests look for signs like DNA methylation patterns or small traces of tumor DNA floating in the bloodstream. The primary goal is early cancer detection, ideally before any symptoms appear, so the overall treatment is more effective and less expensive. Download a free sample report now 👉 https://meditechinsights.com/multi-cancer-early-detection-marke...
Post a Comment
Read more

Global Structural Heart Devices Market growth 9% CAGR with favorable reimbursement scenarios 2030

  The global structural heart devices market is set to witness a CAGR of ~9% in the next 5 years.  The rising geriatric population & corresponding rise in the prevalence of heart disease, technological advancements in structural heart devices, regulatory approval for expanded indications for several transcatheter heart valves, and increasing awareness and favorable reimbursements for these procedures in key markets are some of the pivotal factors driving the growth of the structural heart devices market. However, high device costs, complex procedures, and stringent regulatory hurdles continue to restrain market uptake.  Structural heart disease occurs when something is wrong with one’s heart valves, walls, chambers or muscles. It exists from birth or develops as one age. It includes conditions such as congenital heart disease, cardiomyopathy, and heart valve disease. Heart valve devices, occluders & delivery systems, annuloplasty rings, heart access systems, cl...
Post a Comment
Read more